On May 11, Washington, D.C. litigation head Jennifer Bragg participated in the panel “Maintaining Effective and Compliant HCP Relations in Practice: How Life Sciences Companies are Dovetailing Operationally Efficient Processes With Required Checks and Balances” during ACI’s FCPA & Anti-Corruption for the Life Sciences Industry Conference. Topics included operationalizing compliant health care personnel (HCP) engagement strategies, and key violations and investigations involving interactions with HCP, among others.